HRT Financial
MENS icon

HRT Financial’s Jyong Biotech MENS Stock Holding History

HRT Financial’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
50,423
+38,656
+329% +$82K ﹤0.01% 3605
2026
Q1 		$25K Buy
+11,767
New +$28.8K ﹤0.01% 3547
2025
Q4 		– Sell
-20,819
Closed -$819K – 4330
2025
Q3 		$819K Sell
20,819
-2,103
-9% -$75.7K ﹤0.01% 1627
2025
Q2 		$190K Buy
+22,922
New +$197K ﹤0.01% 2091

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HRT Financial's MENS Position: Q2 2026 in Review

HRT Financial increased its Jyong Biotech (MENS) stake by 329% in Q2 2026, buying an estimated $82K and bringing the position to 50,423 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3605.

HRT Financial first reported a position in MENS in Q2 2025 and has held it in 4 quarters since. The position peaked at $819K in Q3 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • HRT Financial held 50,423 shares of Jyong Biotech worth $104K as of Q2 2026.
  • HRT Financial bought 38,656 Jyong Biotech shares in Q2 2026, an estimated $82K.
  • Jyong Biotech made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3605 holding.
  • HRT Financial first reported a position in Jyong Biotech in Q2 2025 and has held it in 4 quarters since.
  • HRT Financial's Jyong Biotech position peaked at $819K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.